MoonLake Immunotherapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 05/15/2026 | 16.00 M | $298.26 M | -18.99% | 22.45% |
| DEEP TRACK CAPITAL, LP | 05/15/2026 | 6.41 M | $119.46 M | 39.02% | 8.99% |
| CORMORANT ASSET MANAGEMENT, LP | 05/15/2026 | 4.48 M | $83.52 M | 2.87% | 6.29% |
| JANUS HENDERSON GROUP PLC | 05/18/2026 | 3.45 M | $64.30 M | 64.68% | 4.84% |
| D. E. SHAW & CO., INC. | 05/15/2026 | 2.39 M | $44.56 M | -3.63% | 3.35% |
| BIOIMPACT CAPITAL LLC | 05/15/2026 | 1.81 M | $33.76 M | 100.00% | 2.54% |
| WEISS ASSET MANAGEMENT LP | 05/15/2026 | 1.71 M | $31.84 M | 413.07% | 2.40% |
| LOGOS GLOBAL MANAGEMENT LP | 05/15/2026 | 1.50 M | $27.96 M | -14.29% | 2.10% |
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 1.37 M | $25.51 M | 77.15% | 1.92% |
| CITADEL ADVISORS LLC | 05/15/2026 | 1.32 M | $24.67 M | 247.54% | 1.86% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 05/15/2026 | 1.29 M | $24.14 M | 34.94% | 1.82% |
| GOLDMAN SACHS GROUP INC | 05/15/2026 | 1.13 M | $21.07 M | 317.58% | 1.59% |
| TWO SIGMA INVESTMENTS, LP | 05/15/2026 | 1.12 M | $20.92 M | 43.00% | 1.57% |
| JPMORGAN CHASE & CO | 05/13/2026 | 1.09 M | $18.43 M | 29.93% | 1.53% |
| BALYASNY ASSET MANAGEMENT L.P. | 05/15/2026 | 1.07 M | $19.86 M | -32.17% | 1.50% |
| BLACKROCK, INC. | 05/13/2026 | 1.02 M | $19.05 M | 256.55% | 1.43% |
| VIVO CAPITAL, LLC | 05/20/2026 | 1.00 M | $18.64 M | 0.00% | 1.40% |
| CANDRIAM S.C.A. | 04/30/2026 | 818.13 K | $15.25 M | 509.05% | 1.15% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 724.79 K | $13.51 M | 5,255.75% | 1.02% |
| CITADEL ADVISORS LLC | 05/15/2026 | 664.00 K | $12.38 M | -55.52% | 0.93% |
| MORGAN STANLEY | 05/15/2026 | 614.48 K | $11.45 M | -41.17% | 0.86% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 601.60 K | $11.21 M | 23.00% | 0.84% |
| HOLOCENE ADVISORS, LP | 05/15/2026 | 600.00 K | $11.18 M | 100.00% | 0.84% |
| MILLENNIUM MANAGEMENT LLC | 05/15/2026 | 576.09 K | $10.74 M | -28.23% | 0.81% |
| JEFFERIES FINANCIAL GROUP INC. | 05/08/2026 | 500.00 K | $9.32 M | 0.00% | 0.70% |
| GREAT POINT PARTNERS LLC | 05/15/2026 | 500.00 K | $9.32 M | 100.00% | 0.70% |
| TREXQUANT INVESTMENT LP | 05/15/2026 | 495.34 K | $9.23 M | 168.74% | 0.70% |
| HRT FINANCIAL LP | 05/14/2026 | 487.58 K | $9.09 M | -23.32% | 0.68% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 05/18/2026 | 457.14 K | $8.52 M | 100.00% | 0.64% |
| JANE STREET GROUP, LLC | 05/12/2026 | 453.63 K | $8.46 M | -73.03% | 0.64% |
| CASDIN CAPITAL, LLC | 05/15/2026 | 450.00 K | $8.39 M | 100.00% | 0.63% |
| LONGAEVA PARTNERS L.P. | 05/15/2026 | 410.00 K | $7.64 M | 100.00% | 0.58% |
| VOLEON CAPITAL MANAGEMENT LP | 05/15/2026 | 373.02 K | $6.95 M | -25.26% | 0.52% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 341.42 K | $6.36 M | -37.84% | 0.48% |
| JUMP FINANCIAL, LLC | 05/14/2026 | 325.97 K | $6.08 M | -23.40% | 0.46% |
| WALLEYE CAPITAL LLC | 05/13/2026 | 320.47 K | $5.97 M | 323.05% | 0.45% |
| FIRST TURN MANAGEMENT, LLC | 05/15/2026 | 315.56 K | $5.88 M | 20.15% | 0.44% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 276.77 K | $5.16 M | 105.82% | 0.39% |
| BOXER CAPITAL MANAGEMENT, LLC | 05/15/2026 | 275.00 K | $5.13 M | 0.00% | 0.39% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/15/2026 | 265.60 K | $4.95 M | 35.72% | 0.37% |
| SUSQUEHANNA PORTFOLIO STRATEGIES, LLC | 05/15/2026 | 253.97 K | $4.73 M | 0.00% | 0.36% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 239.84 K | $4.47 M | 2,020.58% | 0.34% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 05/14/2026 | 239.50 K | $4.46 M | -34.20% | 0.34% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 05/15/2026 | 220.60 K | $4.11 M | 11.24% | 0.31% |
| EXOME ASSET MANAGEMENT LLC | 05/15/2026 | 215.38 K | $4.01 M | 100.00% | 0.30% |
| HIGHVISTA STRATEGIES LLC | 05/15/2026 | 193.96 K | $3.62 M | 100.00% | 0.27% |
| ACUTA CAPITAL PARTNERS, LLC | 05/15/2026 | 191.76 K | $3.57 M | 223.48% | 0.27% |
| CONGRESS ASSET MANAGEMENT CO /MA | 04/14/2026 | 178.56 K | $3.33 M | 151.15% | 0.25% |
| 05/15/2026 | 175.73 K | $3.28 M | 0.00% | 0.25% | |
| 05/15/2026 | 174.25 K | $3.25 M | 100.00% | 0.24% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MoonLake Immunotherapeutics institutional Ownership - FAQ's
During the previous two years, 191 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were:
Capricorn Fund Managers Ltd: 374,866
Walleye Capital LLC: 246,869
Y-Intercept (Hong Kong) Ltd: 215,849
CONGRESS ASSET MANAGEMENT CO /MA: 180,448
TD ASSET MANAGEMENT INC: 128,274
GSA CAPITAL PARTNERS LLP: 106,695
88.46% of MoonLake Immunotherapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 65.78 M shares in the last 24 months. This purchase volume represents approximately $1.21 B in transactions.